Close Menu

Small Wins Big

This week, The Scientist ranks readers' picks for the top 40 places to work in industry in 2011. Notably, the top three firms overall are each staffed by no more than 100 employees. This year, Epizyme — the Cambridge, Mass.-based drug-development company, which has fewer than 50 employees — takes top honors. The Scientist notes the firm's "integrity" and "communications" as its greatest strengths.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.

NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.

In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.

Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.